The Children’s Hospital of Philadelphia has partnered with Beijing Genomics Institute, or BGI, the largest genomics institute in the world, to do large-scale human sequencing and bioinformatics analysis at the Joint Genome Center at the hospital.BGI@CHOP will focus on genes that underpin rare and common pediatric diseases using next-generation sequencing. CHOP has expertise in clinical [...]

Merck (NYSE:MRK) posted net income of $1.6 billion in the third quarter, eclipsing its performance for the same time last year, aided by its cervical cancer vaccine and strong growth in China.Revenue for the Whitehouse Station, New Jersey pharmaceutical company for the quarter rose 8 percent to $12 billion. Sales of combination diabetes drug Janumet [...]

Drexel University in Philadelphia has signed an agreement with Shanghai Advanced Research Institute in a move to produce more collaboration between faculty and researchers at the institutions.John A. Fry, Drexel’s president, announced the launch of the Drexel-SARI center in Shanghai with the president of the Shanghai Advanced Research Institute, Dr. Feng Songlin.One of the first [...]

A Cleveland venture capitalist who co-founded Bridge Investment Fund has taken on a new role as a senior adviser to an early stage Chinese investment fund.Michael Goldberg will work with Kaiwu Capital, a China-based venture group, to help the fund identify market and collaboration opportunities for its portfolio companies — particularly in the biomedical industry [...]

Clinical research organization PPD (NYSE:PPDI) has appointed a chief scientific officer for BioDuro, its drug discovery subsidiary in China.Jasmine Cui brings to PPD more than 15 years of drug discovery experience, including 14 years at Merck (NYSE:MRK). Wilmington, North Carolina-based PPD has made China a big part of its business through acquisitions. In 2009, the [...]

Boston Scientific Corp. (NYSE:BSX) sank $150 million into a five-year plan to expand Chinese commercial operations, including establishing a wholly owned manufacturing site and developing training centers for Chinese health care providers.The Natick, Mass.-based med-tech giant also plans to increase its Chinese workforce six-fold from 200 to more than 1,200 while investing further in R&D [...]

Cancer and infectious diseases startup Ascletis, which will operate dual locations in the United States and China, announced Wednesday it will open its U.S. headquarters in Research Triangle Park, North Carolina.But even more significant than the region where Ascletis will operate is the site where it will grow. The company will establish its U.S. operations [...]

GlaxoSmithKline (NYSE:GSK) is coughing up $39 million to buy the remaining stake in a joint venture company formed to make flu vaccines in China.The pharmaceutical giant, which has its U.S. headquarters in Research Triangle Park, North Carolina, announced it has entered into an agreement to acquire the 51 percent stake in Shenzhen Neptunus Interlong Bio-Technique [...]

Cancer and infectious disease therapeutics company Ascletis has raised $100 million in a first round of financing as the new company launches dual operations in China and North Carolina.Ascletis is led by co-founder, President and CEO Jinzi J. Wu, a former GlaxoSmithKline (NYSE:GSK) executive. While based at GSK’s U.S. headquarters in Research Triangle Park, North [...]

GlaxoSmithKline‘s rivalry with top drug companies such as Pfizer goes beyond the products they sell. In some emerging markets, it now also extends to the staff they’re fighting to keep.Bloomberg Businessweek reports that London-based GSK (NYSE:GSK) is in a “war for talent” in China and India as the pharmaceutical company looks to expand in emerging [...]